NDC 68001-265

Etoposide

Etoposide

Etoposide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Etoposide.

Product ID68001-265_30d6f51a-8099-4ff9-9be6-fb0559c88e42
NDC68001-265
Product TypeHuman Prescription Drug
Proprietary NameEtoposide
Generic NameEtoposide
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2013-11-14
Marketing CategoryANDA / ANDA
Application NumberANDA074513
Labeler NameBluePoint Laboratories
Substance NameETOPOSIDE
Active Ingredient Strength20 mg/mL
Pharm ClassesTopoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68001-265-25

1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25) > 5 mL in 1 VIAL, MULTI-DOSE (68001-265-22)
Marketing Start Date2013-11-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68001-265-26 [68001026526]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074513
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-14

NDC 68001-265-24 [68001026524]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074513
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-14

NDC 68001-265-22 [68001026522]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074513
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-14

NDC 68001-265-27 [68001026527]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074513
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-14

NDC 68001-265-23 [68001026523]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074513
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-14

NDC 68001-265-25 [68001026525]

Etoposide INJECTION
Marketing CategoryANDA
Application NumberANDA074513
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-14

Drug Details

Active Ingredients

IngredientStrength
ETOPOSIDE20 mg/mL

OpenFDA Data

SPL SET ID:157d4e0f-806d-4011-9dec-97e2449e507b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310248
  • UPC Code
  • 0368001265225
  • Pharmacological Class

    • Topoisomerase Inhibitor [EPC]
    • Topoisomerase Inhibitors [MoA]
    • Topoisomerase Inhibitor [EPC]
    • Topoisomerase Inhibitors [MoA]

    NDC Crossover Matching brand name "Etoposide" or generic name "Etoposide"

    NDCBrand NameGeneric Name
    0143-9376EtoposideEtoposide
    0143-9510EtoposideEtoposide
    0143-9511EtoposideEtoposide
    0143-9512EtoposideEtoposide
    0378-3266Etoposideetoposide
    16729-114EtoposideEtoposide
    16729-262EtoposideEtoposide
    63323-104EtoposideETOPOSIDE
    68001-265EtoposideEtoposide
    0703-5653ToposarEtoposide
    0703-5656ToposarEtoposide
    0703-5657ToposarEtoposide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.